Marc Sutton
Partner
London, UK
Articles edited by Marc Sutton
- Folding A Shirt With 12-Foot Arms: Understanding Protein Folding in Huntingtonâs Disease
- The First Domino Falls: AMT-130 Gene Therapy Slows Huntingtonâs in Landmark Trial
- Excitement and Anticipation as PTCâs Huntingtonâs Disease Drug Clears a Major Hurdle to Sprint Home
- Do Antidepressants Affect Cognitive Decline? There's More To The Story For Huntington's Disease
- Huntingtonâs Disease Heroes: A Gratitude Day Feature on Factor-H
- Huntington's Disease Therapeutics Conference 2025 – Day 3
- Huntington's Disease Therapeutics Conference 2025 – Day 2
- Spotting HD Early: The Clues Hidden in Young Brains
- Moving into the Fast Lane: uniQure and the FDA Are on the Same Track for Accelerated Approval
- Self-determination on the HD journey: the role of Advanced Care Planning
- Hope vs. hype: seeking truth in recent Prilenia headlines
- Hereditary Disease Foundation (HDF) conference 2024 â Day 4
- Hereditary Disease Foundation (HDF) conference 2024 â Day 3
- Hereditary Disease Foundation (HDF) conference 2024 â Day 2
- A new era for HDBuzz
- Understanding expansions at the single cell level
- Huntington's Disease Therapeutics Conference 2024 – Day 3
- Huntington's Disease Therapeutics Conference 2024 – Day 2
- Huntington's Disease Therapeutics Conference 2024 – Day 1
- Putting it in print: GENERATION HD1 study results published
- Beyond huntingtin lowering: out-of-the-box approaches for the treatment of HD
- Uncovering the dark side of DNA repair to design HD treatments
- Making babies: having a family, the HD way
Articles written by Marc Sutton
- A tug-of-war at the DNA: how Huntingtonâs repeats grow and shrink
- A Map Through Time: Tracking Huntingtonâs Disease From Birth in the Brain
- Huntingtonâs Disease Clinical Research Congress 2025 â Day 3
- Huntingtonâs Disease Clinical Research Congress 2025 â Day 2
- Huntingtonâs Disease Clinical Research Congress 2025 – Day 1
- Full Steam Ahead: uniQureâs On Track With Hope for Accelerated Approval of Huntingtonâs Disease Drug
- Roche provides an update on tominersen: Whatâs next for this huntingtin-lowering drug?
- Huntingtonâs Disease Heroes: A Gratitude Day Feature on Factor-H
- Huntington's Disease Therapeutics Conference 2025 – Day 3
- Huntington's Disease Therapeutics Conference 2025 – Day 2
- Huntington's Disease Therapeutics Conference 2025 – Day 1
- Moving into the Fast Lane: uniQure and the FDA Are on the Same Track for Accelerated Approval
- Huntington Study Group (HSG) Conference 2024 â Day 3
- Huntington Study Group (HSG) Conference 2024 â Day 2
- Huntington Study Group (HSG) Conference 2024 â Day 1
- Hereditary Disease Foundation (HDF) conference 2024 â Day 4
- Hereditary Disease Foundation (HDF) conference 2024 â Day 3
- Hereditary Disease Foundation (HDF) conference 2024 â Day 2
- Hereditary Disease Foundation (HDF) conference 2024 â Day 1
- A new era for HDBuzz
- Huntington's Disease Therapeutics Conference 2024 – Day 3
- Huntington's Disease Therapeutics Conference 2024 – Day 2
- Huntington's Disease Therapeutics Conference 2024 – Day 1
- Putting it in print: GENERATION HD1 study results published
- Drug to treat movement symptoms of HD approved by FDA
- Updates from PTC Therapeutics and uniQure on their huntingtin-lowering trials
- Huntingtonâs disease therapeutics conference 2023 – Day 3
- Huntingtonâs disease therapeutics conference 2023 – Day 2
- Huntingtonâs disease therapeutics conference 2023 – Day 1
- Hunting for balance: how the huntingtin protein compensates in HD
- Update on the PTC Therapeutics PIVOT-HD Trial
- Forward momentum for Roche and Wave in latest news about huntingtin-lowering trials
- Hereditary Disease Foundation (HDF) conference 2022 â Day 4
- Hereditary Disease Foundation (HDF) conference 2022 â Day 3
- Hereditary Disease Foundation (HDF) conference 2022 â Day 2
- Hereditary Disease Foundation (HDF) conference 2022 â Day 1
- Serious side effects reported for some people treated with the huntingtin-lowering drug AMT-130, currently in clinical trials
- Updates from uniQure about their gene therapy for Huntington's disease
- Revisiting vitamin therapy for HD
- Huntingtonâs disease therapeutics conference 2022 – Day 3
- Huntingtonâs disease therapeutics conference 2022 – Day 1
- Huntingtonâs disease therapeutics conference 2022 – Day 2
- Oral drug may change the story for huntingtin lowering
- Finding the silver lining: an update on the Roche GENERATION-HD1 trial data
- Real talk: Q&A with Roche about GENERATION-HD1
- Unpacking recent gene therapy press
- Huntington's disease therapeutics conference 2021 – Day 3
- Huntingtonâs disease therapeutics conference 2021 – Day 1
- Huntington's disease therapeutics conference 2021 – Day 2
- Disappointing Results from Waveâs PRECISION-HD1 and 2 Trials
- Sad News from Roche and Ionis – ASO Trial Halted Early
- Vaccines and HD
- Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus – Day 2
- When genes are unstable: targeting somatic instability in HD
- Fountain of youth: HTT protein repairs neurons by maintaining youthful state
- What does COVID-19 mean for Huntingtonâs disease families and HD research?
- Huntingtonâs disease therapeutics conference 2020 – Day 3
- Huntingtonâs disease therapeutics conference 2020 – Day 2
- Huntingtonâs disease therapeutics conference 2020 – Day 1
- Huntington's disease therapeutics conference 2019 – Day 3
- Huntington's disease therapeutics conference 2019 – Day 2
- HDBuzz primer: Clinical trial designs and phases
- Start here!
- Making babies: having a family, the HD way
Articles translated by Marc Sutton
çźäœäžæ
Français
Nederlands
- 10 Gouden Regels voor het Navigeren door Onderzoeksnieuws over de ziekte van Huntington
- Wakker worden: Slaap wordt beĂŻnvloed voordat symptomen van de ziekte van Huntington verschijnen
- Terugblik op 2024
- BĂštablokkers geassocieerd met vertraagde aanvang en verminderde progressie van de ziekte van Huntington
- Kunnen spierproblemen helpen bij het verklaren van bewegingen bij de ziekte van Huntington?
- Genonderdrukkend medicijn veilig bij ALS-patiĂ«nten… op naar Huntington-trials
PortuguĂȘs
- PrĂ©mio HDBuzz 2024: CompetĂȘncias Sociais – A Joia Escondida na Melhoria da Qualidade de Vida das Pessoas com Doença de Huntington?
- Um novo mapa para seguir a progressão da doença de Huntington
- Fazer bebĂ©s: ter uma famĂlia, Ă maneira da DH
Deutsch
- Ein fehlerhafter Filter? BlutgefĂ€ĂverĂ€nderungen bei der Huntington-Krankheit
- Impfungen und die Huntington-Krankheit
- Huntington's Disease Therapeutics Conference 2019 – Tag 1
- Die Vorteile der Migration, hervorgehoben bei der Huntington-Krankheit
- Huntingtin greift zum Hammer: DNA-Reparatur bei HD
- Leider hat die PRIDE-HD-Studie NICHT gezeigt, dass Pridopidin das Fortschreiten der Huntington-Krankheit verlangsamt.
- Huntingtin macht einen Ausflug: schÀdliche Proteine verbreiten sich in Hirnzellen
- Gemeinsam BĂ€ume pflanzen: Die Jahrestagung 2016 der Huntington’s Disease Society of America
- Deutetrabenazin fĂŒr Huntington: positive Studienergebnisse aber die FDA sagt nein? Nicht unbedingt…